Suppr超能文献

急性髓系白血病异基因造血干细胞移植中清髓性与减低强度预处理方案的比较:一项队列研究

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.

作者信息

Çiftçiler Rafiye, Göker Hakan, Demiroğlu Haluk, Aladağ Elifcan, Aksu Salih, Haznedaroğlu İbrahim Celalettin, Sayınalp Nilgün, Özcebe Osman, Tekin Fatma, Büyükaşık Yahya

机构信息

Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Turkey

出版信息

Turk J Haematol. 2019 May 3;36(2):88-96. doi: 10.4274/tjh.galenos.2019.2018.0220. Epub 2019 Feb 5.

Abstract

OBJECTIVE

Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment modality for a variety of malignant and non-malignant hematologic disorders. Myeloablative conditioning (MAC) and reduced-intensity conditioning (RIC) regimens could have different clinical outcomes. This purpose of this study was to assess the long-term outcome of MAC versus RIC regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic HSCT.

MATERIALS AND METHODS

We retrospectively compared long-term outcomes with MAC and RIC regimens in patients with AML who underwent allo-HSCT at our tertiary transplantation center.

RESULTS

We analyzed survival outcomes after MAC-HSCT versus RICHSCT among 107 adult patients with AML diagnosed from 2001 through 2017. Of those, 44 patients underwent a MAC regimen, whereas 63 patients received a RIC regimen. The median follow-up time was 37 months (range: 6-210) for the entire group. The 3-year overall survival (OS) for RIC and MAC patients was 67% and 60%, respectively (p>0.05). The 3-year progression-free survival (PFS) for RIC and MAC patients was 88% and 77%. In multivariate analysis, the type of conditioning regimen (RIC vs. MAC) did not influence PFS (p=0.24). Acute graft-versus-host disease (GVHD) was seen in five of the RIC patients and 9 of the MAC patients. Chronic GVHD was seen in 16 of the RIC patients and 6 of the MAC patients. There was no significant difference between the two groups in terms of acute GVHD (p=0.089), but there was a significant difference between the two groups in terms of chronic GVHD (p=0.03).

CONCLUSION

This retrospective analysis confirmed that MAC and RIC regimens had a consistently equivalent rate of OS and PFS in AML patients who underwent allo-HSCT. The choice of MAC versus RIC conditioning regimen might be decided on the basis of patient and disease characteristics.

摘要

目的

异基因造血干细胞移植(HSCT)是治疗多种恶性和非恶性血液系统疾病的有效方法。清髓性预处理(MAC)和减低强度预处理(RIC)方案可能会产生不同的临床结果。本研究旨在评估接受异基因HSCT的急性髓系白血病(AML)患者中MAC方案与RIC方案的长期疗效。

材料与方法

我们回顾性比较了在我们三级移植中心接受异基因HSCT的AML患者中MAC方案与RIC方案的长期疗效。

结果

我们分析了2001年至2017年诊断的107例成年AML患者中MAC-HSCT与RIC-HSCT后的生存结果。其中,44例患者接受了MAC方案,而63例患者接受了RIC方案。整个组的中位随访时间为37个月(范围:6-210个月)。RIC组和MAC组患者的3年总生存率(OS)分别为67%和60%(p>0.05)。RIC组和MAC组患者的3年无进展生存率(PFS)分别为88%和77%。多因素分析中,预处理方案类型(RIC与MAC)不影响PFS(p=0.24)。RIC组5例患者和MAC组9例患者发生急性移植物抗宿主病(GVHD)。RIC组16例患者和MAC组6例患者发生慢性GVHD。两组在急性GVHD方面无显著差异(p=0.089),但在慢性GVHD方面两组有显著差异(p=0.03)。

结论

这项回顾性分析证实,在接受异基因HSCT的AML患者中,MAC方案和RIC方案的OS和PFS率始终相当。MAC方案与RIC预处理方案的选择可根据患者和疾病特征来决定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/047f/6516104/2167cdc22112/TJH-36-88-g5.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验